EZH2 and breast cancer: Similarly, Lee ST and colleagues identified that in estrogen receptor (ER)-negative basal-like breast cancer cells, EZH2 binds to a NF-κB component to form a ternary complex, leading to transcriptional activation of its downstream target genes.